Portola Pharmaceuticals, Inc.

Q4 2014 13F Holders

Symbol
PTLA
CUSIP
737010108
Type
Equity
Class
COM
Num filings
137
Total reported value, excl. options
$1.26 B
Manager Report Date Value ($000) Shares Option Type